Vimarsana
Biggest News Aggregation in the World

Nasdaq Tern News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Tern. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Tern Today - Breaking & Trending Today

Terns Pharmaceuticals (NASDAQ:TERN) Earns "Neutral" Rating from HC Wainwright - Vimarsana News

Terns Pharmaceuticals (NASDAQ:TERN) Earns "Neutral" Rating from HC Wainwright

HC Wainwright reissued their neutral rating on shares of Terns Pharmaceuticals (NASDAQ:TERN – Free Report) in a research note issued to investors on Tuesday, Benzinga reports. The brokerage currently has a $5.50 price target on the stock. A number of other research analysts have also commented on TERN. JMP Securities decreased their price target on […]

Terns Pharmaceuticals (NASDAQ:TERN) Given "Neutral" Rating at HC Wainwright - Vimarsana News

Terns Pharmaceuticals (NASDAQ:TERN) Given "Neutral" Rating at HC Wainwright

HC Wainwright reaffirmed their neutral rating on shares of Terns Pharmaceuticals (NASDAQ:TERN – Free Report) in a report issued on Tuesday, Benzinga reports. They currently have a $5.50 target price on the stock. Several other research firms have also issued reports on TERN. JMP Securities lowered their price target on Terns Pharmaceuticals from $17.00 to […]

Terns Pharmaceuticals (NASDAQ:TERN) Earns Market Outperform Rating from JMP Securities - Vimarsana News

Terns Pharmaceuticals (NASDAQ:TERN) Earns Market Outperform Rating from JMP Securities

JMP Securities reiterated their market outperform rating on shares of Terns Pharmaceuticals (NASDAQ:TERN – Free Report) in a research note released on Tuesday morning, Benzinga reports. JMP Securities currently has a $15.00 target price on the stock. Other analysts also recently issued research reports about the stock. BMO Capital Markets increased their target price on […]

Brokerages Set Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Price Target at $14.94 - Vimarsana News

Brokerages Set Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Price Target at $14.94

Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) have been given an average rating of “Moderate Buy” by the eight analysts that are covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average twelve-month […]

Brokerages Set Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Target Price at $14.94 - Vimarsana News

Brokerages Set Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Target Price at $14.94

Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eight research firms that are currently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The […]